Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study, Arch Intern Med, vol.158, issue.6, pp.585-93, 1998. ,
The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism, J Gen Intern Med, vol.21, issue.7, pp.722-729, 2006. ,
The post-PE syndrome: a new concept for chronic complications of pulmonary embolism, Blood Rev, vol.28, issue.6, pp.221-227, 2014. ,
Perfusion defects after pulmonary embolism: risk factors and clinical significance, J Thromb Haemost JTH, vol.8, issue.6, pp.1248-55, 2010. ,
Long-term clinical course of acute pulmonary embolism, Blood Rev, vol.27, issue.4, pp.185-92, 2013. ,
Quality of life in long-term survivors of acute pulmonary embolism, Chest, vol.138, issue.6, pp.1432-1472, 2010. ,
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism, N Engl J Med, vol.350, issue.22, pp.2257-64, 2004. ,
Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism, Thromb Haemost, vol.112, issue.3, pp.598-605, 2014. ,
Chronic thromboembolic pulmonary hypertension ,
, , vol.364, pp.351-60, 2011.
Update on chronic thromboembolic pulmonary hypertension, Circulation, vol.130, issue.6, pp.508-526, 2014. ,
From Acute to Chronic Thromboembolic Disease, vol.13, pp.207-221, 2016. ,
Longterm prognostic value of residual pulmonary vascular obstruction at discharge in patients with intermediate-to high-risk pulmonary embolism, Eur Heart J, vol.34, issue.9, pp.693-701, 2013. ,
Residual perfusion defects in patients with pulmonary embolism are related to impaired fibrinolytic capacity, Thromb Res, vol.134, issue.3, pp.737-778, 2014. ,
Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis, Am J Respir Crit Care Med, vol.173, issue.11, pp.1270-1275, 2006. ,
Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic, Am J Respir Crit Care Med, vol.181, issue.9, pp.992-998, 2010. ,
High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension, Blood, vol.114, issue.9, pp.1929-1965, 2009. ,
Chronic thromboembolic pulmonary hypertension-associated dysfibrinogenemias exhibit disorganized fibrin structure, Thromb Res, vol.132, issue.6, pp.729-763, 2013. ,
Structural insights into fibrinogen dynamics using amide hydrogen/deuterium exchange mass spectrometry. Biochemistry (Mosc), vol.52, pp.5491-502, 2013. ,
Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot, Biol Pharm Bull, vol.16, issue.5, pp.448-52, 1993. ,
Abnormally sialylated fibrinogen gamma-chains in a patient with chronic thromboembolic pulmonary hypertension, Thromb Res, vol.119, issue.2, pp.257-266, 2007. ,
Association of influenza vaccination with reduced risk of venous thromboembolism, Thromb Haemost, vol.102, issue.6, pp.1259-64, 2009. ,
Pulmonary nuclear medicine, Eur J Nucl Med, vol.19, issue.5, pp.355-68, 1992. ,
Comparison of perfusion lung scanning and angiography in the estimation of vascular obstruction in acute pulmonary embolism, Eur J Nucl Med, vol.17, issue.6-8, pp.315-324, 1990. ,
,
, New CT index to quantify arterial obstruction in pulmonary embolism: comparison with angiographic index and echocardiography, AJR Am J Roentgenol, vol.176, issue.6, pp.1415-1435, 2001.
The value of tomographic ventilation/perfusion scintigraphy (V/PSPECT) for follow-up and prediction of recurrence in pulmonary embolism, Thromb Haemost, vol.130, issue.6, pp.26-34, 2012. ,
Residual pulmonary obstruction and the risk of late complications in patients with pulmonary embolism, Thromb Res, vol.137, pp.228-258, 2016. ,
Prognostic factors in restoration of pulmonary flow after submassive pulmonary embolism: a multiple regression analysis, Eur Respir J, vol.11, issue.3, pp.560-564, 1998. ,
Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis, J Biol Chem, vol.269, issue.45, pp.28414-28423, 1994. ,
,
Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism, J Thromb Haemost JTH, 2016. ,
Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review, JAMA Intern Med, vol.173, issue.12, pp.192-199, 2006. ,
,
, Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison of computed tomography and perfusion scintigraphy, J Thromb Haemost JTH, vol.11, issue.4, pp.679-85, 2013.
Fibrinogen sialic acid residues are low affinity calcium-binding sites that influence fibrin assembly, J Biol Chem, vol.264, issue.25, pp.15104-15112, 1989. ,
The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains, Blood, vol.61, issue.6, pp.1196-202, 1983. ,
The sialic acid content of fibrinogen decreases during pregnancy and increases in response to fibrate therapy, Thromb Res, vol.115, issue.4, pp.293-302, 2005. ,
Fibrinogen and fibrin structure and functions, J Thromb Haemost JTH, vol.3, issue.8, pp.1894-904, 2005. ,
The role of neovascularisation in the resolution of venous thrombus, Thromb Haemost, 2005. ,
The epidemiology of venous thromboembolism in the community ,
, Arterioscler. Thromb. Vasc. Biol, vol.28, issue.3, pp.370-372, 2008.
Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality, Thromb. Haemost, vol.98, issue.4, pp.756-764, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00688301
,
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study, Arch. Intern. Med, vol.158, issue.6, pp.585-593, 1998. ,
The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism, J. Gen. Intern. Med, vol.21, issue.7, pp.722-727, 2006. ,
Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale, Thromb. Haemost, vol.83, issue.5, pp.657-660, 2000. ,
URL : https://hal.archives-ouvertes.fr/hal-00726218
A prospective study of the incidence of deep-vein thrombosis within a defined urban population, J. Intern. Med, vol.232, issue.2, pp.155-160, 1992. ,
Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study, BMJ, vol.343, p.4656, 2011. ,
Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France, Thromb. Haemost, vol.116, issue.5, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01561314
Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER), Lancet Lond. Engl, vol.353, issue.9162, pp.1386-1389, 1999. ,
Predictive accuracy of 29-comorbidity index for in-hospital deaths in US adult hospitalizations with a diagnosis of venous thromboembolism, PloS One, vol.8, issue.7, p.70061, 2013. ,
A positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients, Thromb. Haemost, vol.95, issue.6, pp.963-966, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00689549
Further validation and simplification of the Wells clinical decision rule in pulmonary embolism, Thromb. Haemost, vol.99, issue.1, pp.229-234, 2008. ,
, Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism, Lancet Lond. Engl, vol.340, issue.8824, pp.873-876, 1992.
A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group, N. Engl. J. Med, vol.332, issue.25, pp.1661-1665, 1995. ,
The long-term clinical course of acute deep venous thrombosis, Ann. Intern. Med, vol.125, issue.1, pp.1-7, 1996. ,
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism, N. Engl. J. Med, vol.340, issue.12, pp.901-907, 1999. ,
Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study, Lancet Lond. Engl, vol.362, issue.9383, pp.523-526, 2003. ,
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the, Eur. Heart J, 2014. ,
Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report, Chest, vol.149, issue.2, pp.315-352, 2016. ,
Mortality in patients treated for pulmonary embolism, JAMA, vol.236, issue.13, pp.1477-1480, 1976. ,
Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism, Medicine (Baltimore), vol.85, issue.5, pp.253-262, 2006. ,
Incomplete recovery of lung perfusion after 3 months in patients with acute pulmonary embolism treated with antithrombotic agents. THESEE Study Group. Tinzaparin ou Heparin Standard: Evaluation dans l'Embolie Pulmonaire Study, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.41, issue.6, pp.1043-1048, 2000. ,
A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group ,
URL : https://hal.archives-ouvertes.fr/hal-00722358
, N. Engl. J. Med, vol.337, issue.10, pp.663-669, 1997.
Resolution of pulmonary embolism on CT pulmonary angiography, AJR Am. J. Roentgenol, vol.194, issue.5, pp.1263-1268, 2010. ,
The rate of resolution of clot burden measured by pulmonary CT angiography in patients with acute pulmonary embolism, AJR Am. J. Roentgenol, vol.200, issue.4, pp.791-797, 2013. ,
Long-term prognostic value of residual pulmonary vascular obstruction at discharge in patients with intermediate-to high-risk pulmonary embolism, Eur. Heart J, vol.34, issue.9, pp.693-701, 2013. ,
Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison of computed tomography and perfusion scintigraphy, J. Thromb. Haemost. JTH, vol.11, issue.4, pp.679-685, 2013. ,
Tomographic ventilation/perfusion lung scintigraphy in the monitoring of the effect of treatment in pulmonary embolism: serial follow-up over a 6-month period, Nucl. Med. Commun, vol.32, issue.6, pp.508-514, 2011. ,
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism, N. Engl. J. Med, vol.366, issue.14, pp.1287-1297, 2012. ,
Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events, Am. J. Respir. Crit. Care Med, vol.181, issue.5, pp.501-506, 2010. ,
Predicting the risk of venous thromboembolism recurrence, Am. J. Hematol, vol.87, pp.63-67, 2012. ,
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial, JAMA, vol.314, issue.1, pp.31-40, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01259554
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months, J. Thromb. Haemost. JTH, vol.4, issue.4, pp.734-742, 2006. ,
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism, N. Engl. J. Med, vol.350, issue.22, pp.2257-2264, 2004. ,
Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism, Thromb. Haemost, vol.112, issue.3, pp.598-605, 2014. ,
Chronic thromboembolic pulmonary hypertension, N. Engl. J. Med, vol.364, issue.4, pp.351-360, 2011. ,
From Acute to Chronic Thromboembolic Disease, Ann. Am. Thorac. Soc, vol.13, pp.207-214, 2016. ,
Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding, Eur. Respir. J, vol.41, issue.2, pp.462-468, 2013. ,
Determinants of health-related quality of life during the 2 years following deep vein thrombosis, J. Thromb. Haemost. JTH, vol.6, issue.7, pp.1105-1112, 2008. ,
Kearon, and Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, J. Thromb. Haemost. JTH, vol.7, issue.5, pp.879-883, 2009. ,
The post-PE syndrome: a new concept for chronic complications of pulmonary embolism, Blood Rev, vol.28, issue.6, pp.221-226, 2014. ,
The clinical profile of unresolved pulmonary embolism, Chest, vol.84, issue.6, pp.669-678, 1983. ,
Reproducibility of multi-detector spiral computed tomography in detection of subsegmental acute pulmonary embolism, Eur. Radiol, vol.15, issue.10, pp.2057-2063, 2005. ,
New CT index to quantify arterial obstruction in pulmonary embolism: comparison with angiographic index and echocardiography, AJR Am. J. Roentgenol, vol.176, issue.6, pp.1415-1420, 2001. ,
Chronic thromboembolism: diagnosis with helical CT and MR imaging with angiographic and surgical correlation, Radiology, vol.204, issue.3, pp.695-702, 1997. ,
Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography, Eur. J. Radiol, vol.71, issue.1, pp.49-54, 2009. ,
Perfusion defects after pulmonary embolism: risk factors and clinical significance, J. Thromb. Haemost. JTH, vol.8, issue.6, pp.1248-1255, 2010. ,
Residual pulmonary obstruction and the risk of late complications in patients with pulmonary embolism, Thromb. Res, vol.137, pp.228-230, 2016. ,
Thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism, Thromb. Haemost, vol.114, issue.1, pp.26-34, 2015. ,
, Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED), PIOPED Investigators, vol.263, pp.2753-2759, 1990.
Comparison of perfusion lung scanning and angiography in the estimation of vascular obstruction in acute pulmonary embolism, Eur. J. Nucl. Med, vol.17, issue.6-8, pp.315-319, 1990. ,
Residual emboli on lung perfusion scan or multidetector computed tomography after a first episode of acute pulmonary embolism, Intern. Emerg. Med, vol.6, issue.6, pp.521-528, 2011. ,
Long-term outcome of patients with persistent vascular obstruction on computed tomography pulmonary angiography 6 months after acute pulmonary embolism, Acta Radiol. Stockh. Swed, vol.53, issue.7, pp.728-731, 1987. ,
Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.48, issue.5, pp.680-684, 2007. ,
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), 2015. ,
Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review, Chest, vol.129, issue.1, pp.192-197, 2006. ,
Persistent dyspnea complaints at long-term follow-up after an episode of acute pulmonary embolism: results of a questionnaire, Eur. J. Intern. Med, vol.19, issue.8, pp.625-629, 2008. ,
Prevalence and potential determinants of exertional dyspnea after acute pulmonary embolism, Respir. Med, vol.104, issue.11, pp.1744-1749, 2010. ,
Echocardiographic and functional cardiopulmonary problems 6 months after first-time pulmonary embolism in previously healthy patients, Eur. Heart J, vol.28, issue.20, pp.2517-2524, 2007. ,
Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure, Chest, vol.136, issue.5, pp.1202-1210, 2009. ,
Cardiorespiratory efficacy of thrombolytic therapy in acute massive pulmonary embolism: identification of predictive factors, Eur. Respir. J, vol.13, issue.3, pp.610-615, 1999. ,
Inefficient exercise gas exchange identifies pulmonary hypertension in chronic thromboembolic obstruction following pulmonary embolism, Thromb. Res, vol.132, issue.6, pp.659-665, 2013. ,
Quality of life in long-term survivors of acute pulmonary embolism, Chest, vol.138, issue.6, pp.1432-1440, 2010. ,
Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL, Thromb. Res, vol.132, issue.5, pp.500-505, 2013. ,
Estimating quality of life in acute venous thrombosis, JAMA Intern. Med, vol.173, issue.12, pp.1067-1072, 2013. ,
Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study, Arch. Intern. Med, vol.159, issue.5, pp.445-453, 1999. ,
D-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism, Ann. Intern. Med, vol.162, issue.9, p.671, 2015. ,
Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review, Arch. Intern. Med, vol.170, issue.19, pp.1710-1716, 2010. ,
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials, BMJ, vol.342, p.3036, 2011. ,
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients, Haematologica, vol.92, issue.2, pp.199-205, 2007. ,
Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis, J. Thromb. Haemost. JTH, vol.8, issue.11, pp.2436-2442, 2010. ,
Risk of fatal pulmonary embolism in patients with treated venous thromboembolism, JAMA, vol.279, issue.6, pp.458-462, 1998. ,
Extended oral anticoagulant therapy after a first episode of pulmonary embolism, Ann. Intern. Med, vol.139, issue.1, pp.19-25, 2003. ,
Deep vein thrombosis and pulmonary embolism, Lancet Lond. Engl, 2016. ,
Short-Term Risk of Bleeding During Heparin Bridging at Initiation of Vitamin K Antagonist Therapy in More Than 90 000 Patients With Nonvalvular Atrial Fibrillation Managed in Outpatient Care, J. Am. Heart Assoc, vol.5, issue.11, 2016. ,
Venous thromboembolism in the elderly. A community-based perspective, Thromb. Haemost, vol.100, issue.5, pp.780-788, 2008. ,
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients, Kearon, and Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, vol.3, pp.692-694, 2005. ,
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment, Eur. Respir. J, 2016. ,
Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH, J. Thromb. Haemost. JTH, vol.14, issue.7, pp.1480-1483, 2016. ,
Extended anticoagulation and mortality in venous thromboembolism. A meta-analysis of six randomized trials, Thromb. Res, vol.139, pp.22-28, 2016. ,
D-dimer testing to determine the duration of anticoagulation therapy, N. Engl. J. Med, vol.355, issue.17, pp.1780-1789, 2006. ,
D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study, Blood, vol.124, issue.2, pp.196-203, 2014. ,
Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism, Ann. Intern. Med, vol.149, issue.7, pp.481-490, 2008. ,
Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE, BMJ Open, vol.6, issue.5, p.11190, 2016. ,
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy, CMAJ Can. Med. Assoc. J. J. Assoc. Medicale Can, vol.179, issue.5, pp.417-426, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00685547
Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH), J. Thromb. Haemost. JTH, vol.10, issue.6, pp.1019-1025, 2012. ,
Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data, J. Thromb. Haemost. JTH, vol.13, issue.5, pp.775-781, 2015. ,
Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism, Ann. Intern. Med, vol.137, issue.12, pp.955-960, 2002. ,
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis, Thromb. Haemost, vol.111, issue.1, pp.172-179, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-00933950
The value of tomographic ventilation/perfusion scintigraphy (V/PSPECT) for follow-up and prediction of recurrence in pulmonary embolism, Thromb. Res, vol.130, issue.6, pp.877-881, 2012. ,
Risk of recurrence in patients with pulmonary embolism: predictive role of D-dimer and of residual perfusion defects on lung scintigraphy, Thromb. Haemost, vol.109, issue.2, pp.181-186, 2013. ,
Updated clinical classification of pulmonary hypertension, J. Am. Coll. Cardiol, vol.54, issue.1, pp.43-54, 2009. ,
Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism, Chest, vol.130, issue.1, pp.172-175, 2006. ,
Long-term outcomes in acute pulmonary thromboembolism: the incidence of chronic thromboembolic pulmonary hypertension and associated risk factors, Clin. Appl. Thromb. Off. J. Int. Acad. Clin. Appl. Thromb, vol.18, issue.3, pp.281-288, 2012. ,
Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism, Haematologica, vol.95, issue.6, pp.970-975, 2010. ,
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry, Circulation, vol.124, issue.18, 1973. ,
Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension, Thromb. Haemost, vol.93, issue.3, pp.512-516, 2005. ,
Chronic thromboembolic pulmonary hypertension associated with indwelling Port-A-Cath central venous access systems, Am J Respir Crit Care Med, vol.183, p.2409, 2011. ,
Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension, Arterioscler. Thromb. Vasc. Biol, vol.28, issue.4, pp.678-684, 2008. ,
Timing of NT-pro-BNP sampling for predicting adverse outcome after acute pulmonary embolism, Thromb. Haemost, vol.104, issue.1, pp.189-190, 2010. ,
Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension, Am. J. Physiol. Lung Cell. Mol. Physiol, vol.296, issue.6, pp.870-878, 2009. ,
Elevated expression of urokinase-like plasminogen activator and plasminogen activator inhibitor type 1 during the vascular remodeling associated with pulmonary thromboembolism, Arterioscler. Thromb. Vasc. Biol, vol.18, issue.5, pp.808-815, 1998. ,
Resolution of vascular steal after pulmonary thromboendarterectomy, Chest, vol.104, issue.5, pp.1441-1444, 1993. ,
Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction, PloS One, vol.7, issue.8, p.43793, 2012. ,
Fibrinogen and fibrin structure and functions, J. Thromb. Haemost. JTH, vol.3, issue.8, pp.1894-1904, 2005. ,
High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension, Blood, vol.114, issue.9, pp.1929-1936, 2009. ,
Carbohydrate structure of human fibrinogen. Use of 300-MHz 1H-NMR to characterize glycosidase-treated glycopeptides, J. Biol. Chem, vol.257, issue.16, pp.9704-9710, 1982. ,
The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains, Blood, vol.61, issue.6, pp.1196-1202, 1983. ,
Increased carbohydrate content of the fibrinogen molecule, N. Engl. J. Med, vol.299, issue.5, pp.221-226, 1978. ,
Fibrinogen sialic acid residues are low affinity calcium-binding sites that influence fibrin assembly, J. Biol. Chem, vol.264, issue.25, pp.15104-15108, 1989. ,
The amino acid sequence in fibrin responsible for high affinity thrombin binding, Thromb. Haemost, vol.85, issue.3, pp.470-474, 2001. ,
Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma'), Biochemistry (Mosc.), vol.20, issue.21, pp.6146-6149, 1981. ,
Analysis of A alpha 251 fibrinogen: the alpha C domain has a role in polymerization, albeit more subtle than anticipated from the analogous proteolytic fragment X, Biochemistry (Mosc.), vol.37, issue.44, pp.15434-15441, 1998. ,
The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis, Blood, vol.106, issue.12, pp.3824-3830, 2005. ,
Structure of fibrin: impact on clot stability, J. Thromb. Haemost. JTH, vol.5, pp.116-124, 2007. ,
Roles of fibrin ?-and ?-chain specific cross-linking by FXIIIa in fibrin structure and function, Thromb. Haemost, vol.111, issue.5, pp.842-850, 2014. ,
Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis, J. Biol. Chem, vol.269, issue.45, pp.28414-28419, 1994. ,
Identification and characterization of the thrombin binding sites on fibrin, J. Biol. Chem, vol.271, issue.38, pp.23121-23125, 1996. ,
Factor XIII, clot structure, thrombosis, Thromb. Res, vol.129, issue.3, pp.382-387, 2012. ,
Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo, J. Clin. Invest, vol.113, issue.11, pp.1596-1606, 2004. ,
Fibrin activation of vascular endothelial cells. Induction of IL-8 expression, J. Immunol. Baltim. Md, vol.155, issue.2, pp.867-876, 1950. ,
Fibrin induction of ICAM-1 expression in human vascular endothelial cells, J. Immunol. Baltim. Md, vol.158, issue.4, pp.1880-1886, 1950. ,
Inflammation modulates murine venous thrombosis resolution in vivo: assessment by multimodal fluorescence molecular imaging, Arterioscler. Thromb. Vasc. Biol, vol.32, issue.11, pp.2616-2624, 2012. ,
Interaction of fibrin with VEcadherin, Ann. N. Y. Acad. Sci, vol.936, pp.386-405, 2001. ,
Cell proliferation on fibrin: modulation by fibrinopeptide cleavage, Blood, vol.86, issue.5, pp.1802-1810, 1995. ,
VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels, Exp. Cell Res, vol.238, issue.2, pp.324-334, 1998. ,
Endothelial cell VE-cadherin functions as a receptor for the beta15-42 sequence of fibrin, J. Biol. Chem, vol.273, issue.46, pp.30719-30728, 1998. ,
Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: mapping of the receptor-binding site in the NH2-terminal portions of the fibrin beta chains, Biochemistry (Mosc.), vol.41, issue.12, pp.4107-4116, 2002. ,
Accessibility of epitopes on fibrin clots and fibrinogen gels, Blood, vol.77, issue.7, pp.1469-1475, 1991. ,
Degree of polymer organization decreases the binding of a monoclonal antibody raised against the betachain amino terminus of fibrin, Thromb. Haemost, vol.77, issue.4, pp.704-709, 1997. ,
Interaction of fibrin with VE-cadherin and anti-inflammatory effect of fibrin-derived fragments, J. Thromb. Haemost. JTH, vol.9, issue.9, pp.1847-1855, 2011. ,
Identification of VLDLR as a novel endothelial cell receptor for fibrin that modulates fibrin-dependent transendothelial migration of leukocytes, Blood, vol.119, issue.2, pp.637-644, 2012. ,
Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene, J. Biol. Chem, vol.269, issue.3, pp.2173-2182, 1994. ,
Low-density lipoprotein receptor family: endocytosis and signal transduction, Mol. Neurobiol, vol.23, issue.1, pp.53-67, 2001. ,
Analysis of human tissues by in situ hybridization and immunohistochemistry, Am. J. Pathol, vol.148, issue.6, pp.1985-1997, 1996. ,
Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cells, Mol. Biol. Cell, vol.19, issue.2, pp.563-571, 2008. ,
Modulation of lipoprotein receptor functions by intracellular adaptor proteins, Cell. Signal, vol.18, issue.10, pp.1560-1571, 2006. ,
Recent advances in physiological lipoprotein metabolism, Clin. Chem. Lab. Med, vol.52, issue.12, pp.1695-1727, 2014. ,
Interaction of Fibrin with the Very Low Density Lipoprotein Receptor: Further Characterization and Localization of the Fibrin-Binding Site, Biochemistry (Mosc.), vol.54, issue.30, pp.4751-4761, 2015. ,
Loss of VLDL receptor activates retinal vascular endothelial cells and promotes angiogenesis, Invest. Ophthalmol. Vis. Sci, vol.50, issue.2, pp.844-850, 2009. ,
The role of Vldlr in intraretinal angiogenesis in mice, Invest. Ophthalmol. Vis. Sci, vol.52, issue.9, pp.6572-6579, 2011. ,
SalA attenuates ischemia/reperfusion-induced endothelial barrier dysfunction via down-regulation of VLDL receptor expression, Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol, vol.33, issue.3, pp.747-757, 2014. ,
Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity, Blood, vol.103, issue.9, pp.3374-3380, 2004. ,
Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor, J. Biol. Chem, vol.276, issue.15, pp.12241-12248, 2001. ,
VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor, J. Lipid Res, vol.40, issue.5, pp.913-919, 1999. ,
Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein, Arterioscler. Dallas Tex, vol.10, issue.6, pp.1067-1073, 1990. ,
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach, Blood, vol.113, issue.21, pp.5298-5303, 2009. ,
Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels, Blood, vol.106, issue.13, pp.4176-4183, 2005. ,
, alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism, vol.96, pp.1177-1179, 2000.
Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism, Thromb. Res, vol.121, issue.3, pp.333-338, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00688292
The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study, Thromb. Res, vol.121, issue.1, pp.1-7, 2007. ,
Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function, Circulation, vol.107, issue.18, pp.2326-2330, 2003. ,
A hypothesis to explain the reported association of the alpha-fibrinogen A312 allele with thromboembolic disease, Thromb. Haemost, vol.85, issue.6, pp.1122-1123, 2001. ,
Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension, Eur. Respir. J, vol.31, issue.4, pp.736-741, 2008. ,
Fibrinogen A? Thr312Ala polymorphism specifically contributes to chronic thromboembolic pulmonary hypertension by increasing fibrin resistance, PloS One, vol.8, issue.7, p.69635, 2013. ,
Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: identification of polymorphisms at positions A alpha 312 and B beta 448, Blood, vol.82, issue.7, pp.2117-2124, 1993. ,
Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis, Blood, vol.105, issue.3, pp.1102-1105, 2005. ,
Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives, Blood, vol.114, issue.19, pp.4272-4278, 2009. ,
Effects of atorvastatin on plasma fibrin clot properties in apparently healthy individuals and patients with previous venous thromboembolism, Thromb. Haemost, vol.107, issue.6, pp.1180-1182, 2012. ,
Altered fibrin clot properties are associated with residual vein obstruction: effects of lipoprotein(a) and apolipoprotein(a) isoform, Thromb. Res, vol.130, issue.3, pp.184-187, 2012. ,
Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic, Am. J. Respir. Crit. Care Med, vol.181, issue.9, pp.992-996, 2010. ,
Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis, Am. J. Respir. Crit. Care Med, vol.173, issue.11, pp.1270-1275, 2006. ,
Residual perfusion defects in patients with pulmonary embolism are related to impaired fibrinolytic capacity, Thromb. Res, vol.134, issue.3, pp.737-741, 2014. ,
Fibrin clot properties and their modulation in thrombotic disorders, Thromb. Haemost, vol.112, issue.1, pp.32-42, 2014. ,
Chronic thromboembolic pulmonary hypertension-associated dysfibrinogenemias exhibit disorganized fibrin structure, Thromb. Res, vol.132, issue.6, pp.729-734, 2013. ,
Origins of circulating endothelial cells and endothelial outgrowth from blood, J. Clin. Invest, vol.105, issue.1, pp.71-77, 2000. ,
Circulating endothelial cells: realities and promises in vascular disorders, Pathophysiol. Haemost. Thromb, vol.33, issue.5-6, pp.495-499, 2003. ,
Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration, Thromb. Haemost, vol.90, issue.5, pp.915-920, 2003. ,
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes, Blood, vol.105, issue.2, pp.526-532, 2005. ,
Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease, Circulation, vol.119, issue.3, pp.374-381, 2009. ,
Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease, J. Am. Coll. Cardiol, vol.49, issue.7, pp.803-810, 2007. ,
Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening, PloS One, vol.8, issue.6, p.65114, 2013. ,
Circulating endothelial cells in pulmonary hypertension, Thromb. Haemost, vol.90, issue.4, pp.698-703, 2003. ,
Distinct patterns of circulating endothelial cells in pulmonary hypertension, Eur. Respir. J, vol.36, issue.6, pp.1284-1293, 2010. ,
Human Endothelial Progenitor Cells, Cold Spring Harb. Perspect. Med, vol.2, issue.7, 2012. ,
Isolation of putative progenitor endothelial cells for angiogenesis, Science, vol.275, issue.5302, pp.964-967, 1997. ,
Progenitor cells in pulmonary vascular remodeling, Pulm. Circ, vol.1, issue.1, pp.3-16, 2011. ,
The isolation and culture of endothelial colony-forming cells from human and rat lungs, Nat. Protoc, vol.10, issue.11, pp.1697-1708, 2015. ,
Structural and functional characteristics of lung macro-and microvascular endothelial cell phenotypes, Microvasc. Res, vol.67, issue.2, pp.139-151, 2004. ,
Lung microvascular endothelium is enriched with progenitor cells that exhibit vasculogenic capacity, Am. J. Physiol. Lung Cell. Mol. Physiol, vol.294, issue.3, pp.419-430, 2008. ,
Pro-angiogenic hematopoietic progenitor cells and endothelial colony-forming cells in pathological angiogenesis of bronchial and pulmonary circulation, Angiogenesis, vol.14, issue.4, pp.411-422, 2011. ,
Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities, Blood, vol.117, issue.13, pp.3485-3493, 2011. ,
Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells, Am. J. Physiol. Lung Cell. Mol. Physiol, vol.286, issue.4, pp.668-678, 2004. ,
Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension, Am. J. Respir. Crit. Care Med, vol.180, issue.8, pp.780-787, 2009. ,
Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension, Circ. Res, vol.104, issue.11, pp.1293-1301, 2009. ,
Bone Marrow-derived Cells Contribute to the Pathogenesis of Pulmonary Arterial Hypertension, Am. J. Respir. Crit. Care Med, vol.193, issue.8, pp.898-909, 2016. ,
Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension, Angiogenesis, vol.14, issue.1, pp.17-27, 2011. ,
Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells, Thromb. Haemost, vol.114, issue.4, pp.735-747, 2015. ,
Endothelial cells in physiology and in the pathophysiology of vascular disorders, Blood, vol.91, issue.10, pp.3527-3561, 1998. ,
Induction of endothelial cell expression of the plasminogen activator inhibitor type 1 gene by thrombosis in vivo, Circulation, vol.86, issue.6, 1992. ,
Augmented arterial wall expression of type-1 plasminogen activator inhibitor induced by thrombosis, Arterioscler. Thromb. J. Vasc. Biol, vol.12, issue.12, pp.1507-1515, 1992. ,
Defective angiogenesis delays thrombus resolution: a potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertension ,
, Arterioscler. Thromb. Vasc. Biol, vol.34, issue.4, pp.810-819, 2014.
Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells, Circulation, vol.107, issue.6, pp.869-875, 2003. ,
Human peripheral blood endothelial progenitor cells synthesize and express functionally active tissue factor, Thromb. Res, vol.123, issue.6, pp.925-930, 2009. ,
Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells, J. Cell. Mol. Med, vol.12, issue.3, pp.975-986, 2008. ,
The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells, J. Thromb. Haemost. JTH, vol.4, issue.9, pp.2051-2058, 2006. ,
PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system, Arterioscler. Thromb. Vasc. Biol, vol.25, issue.11, pp.2321-2327, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-02163507
Endothelial progenitor cells are recruited into resolving venous thrombi, Circulation, vol.111, issue.20, pp.2645-2653, 2005. ,
Endothelial progenitor cells and thrombosis, Thromb. Res, vol.129, issue.3, pp.309-313, 2012. ,
Coagulation and the vessel wall in pulmonary embolism, Pulm. Circ, vol.3, issue.4, pp.728-738, 2013. ,
Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi, J. Vasc. Surg, vol.32, issue.5, pp.988-996, 2000. ,
Vascular endothelial growth factor enhances venous thrombus recanalisation and organisation, Thromb. Haemost, vol.89, issue.1, pp.169-176, 2003. ,
Endothelial cells organize fibrin clots into structures that are more resistant to lysis, Microsc. Microanal. Off. J. Microsc. Soc. Am. Microbeam Anal. Soc. Microsc. Soc. Can, vol.11, issue.3, pp.268-277, 2005. ,
Fibrin regulation of interleukin-8 gene expression in human vascular endothelial cells, Blood, vol.90, issue.9, pp.3595-3602, 1997. ,
The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury, Nat. Med, vol.11, issue.3, pp.298-304, 2005. ,
Fibrin II induces endothelial cell capillary tube formation, J. Cell Biol, vol.130, issue.1, pp.207-215, 1995. ,
Polymerisation of fibrin ?C-domains promotes endothelial cell migration and proliferation, Thromb. Haemost, vol.112, issue.6, pp.1244-1251, 2014. ,
The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration, Microvasc. Res, vol.51, issue.3, pp.347-364, 1996. ,
Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells, Angiogenesis, vol.2, issue.2, pp.153-165, 1998. ,
Preparation of fibrin glue: a study of chemical and physical methods, J. Appl. Biomater. Off. J. Soc. Biomater, vol.6, issue.3, pp.175-183, 1995. ,
Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots, J. Biol. Chem, vol.278, issue.24, pp.21331-21335, 2003. ,
Circulating endothelial cells and endothelial progenitor cells after angioplasty: news from the endothelial rescue squad, J. Thromb. Haemost. JTH, vol.4, issue.5, pp.976-978, 2006. ,
Detection of circulating endothelial cells: CD146-based magnetic separation enrichment or flow cytometric assay?, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.25, issue.5, pp.1-2, 2007. ,
Native fibrin gel networks observed by 3D microscopy, permeation and turbidity, Biochim. Biophys. Acta, vol.997, issue.1-2, pp.96-110, 1989. ,
Antibodies against the fibrin beta-chain amino-terminus detect active canine venous thrombi, Circulation, vol.96, issue.9, pp.3173-3179, 1997. ,
Use of coefficient of variation in assessing variability of quantitative assays, Clin. Diagn. Lab. Immunol, vol.9, issue.6, pp.1235-1239, 2002. ,
Structural difference between polymerized and nonpolymerized fragment X, obtained by plasmin digest of fibrinogen, Int. J. Biol. Macromol, vol.15, issue.6, pp.323-327, 1993. ,
Fibrinopeptides and fibrin gel structure, Biophys. Chem, vol.112, issue.2-3, pp.147-151, 2004. ,
Structural insights into fibrinogen dynamics using amide hydrogen/deuterium exchange mass spectrometry, Biochemistry (Mosc.), vol.52, issue.32, pp.5491-5502, 2013. ,
Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay, Circulation, vol.129, issue.12, pp.1332-1340, 2014. ,
Circulating endothelial progenitor cells and chronic pulmonary diseases, Eur. Respir. J, vol.37, issue.2, pp.426-431, 2011. ,
Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot, Biol. Pharm. Bull, vol.16, issue.5, pp.448-452, 1993. ,
The sialic acid content of fibrinogen decreases during pregnancy and increases in response to fibrate therapy, Thromb. Res, vol.115, issue.4, pp.293-299, 2005. ,
Flow and antibody binding properties of hydrated fibrins prepared from plasma, platelet rich plasma and whole blood, Thromb. Res, vol.76, issue.2, pp.145-156, 1994. ,
A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis, J. Thromb. Haemost. JTH, vol.3, issue.11, pp.2487-2496, 2005. ,
New developments in the area of factor XIII, J. Thromb. Haemost. JTH, vol.11, issue.2, pp.234-244, 2013. ,
Factor XIII and venous thromboembolism, Semin. Thromb. Hemost, vol.37, issue.3, pp.305-314, 2011. ,
The antifibrinolytic function of factor XIII is exclusively expressed through ??-antiplasmin cross-linking, Blood, vol.117, issue.23, pp.6371-6374, 2011. ,
Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism, J. Am. Coll. Cardiol, vol.19, issue.2, pp.239-245, 1992. ,
Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction, Eur. Heart J, vol.18, issue.7, pp.1141-1148, 1997. ,
Urokinase in pulmonary embolism, Lancet Lond. Engl, vol.2, issue.7827, p.501, 1973. ,
External validation of a simple non-invasive algorithm to rule out chronic thromboembolic pulmonary hypertension after acute pulmonary embolism, Thromb. Res, vol.135, issue.5, pp.796-801, 2015. ,
Fibrinolysis for patients with intermediate-risk pulmonary embolism, N. Engl. J. Med, vol.370, issue.15, pp.1402-1411, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01045144
B?(15-42) attenuates the effect of ischemia-reperfusion injury in renal transplantation, J. Am. Soc. Nephrol. JASN, vol.22, issue.10, pp.1887-1896, 2011. ,
A randomized trial of rosuvastatin in the prevention of venous thromboembolism, N. Engl. J. Med, vol.360, issue.18, pp.1851-1861, 2009. ,
Exercise training-induced different improvement profile of endothelial progenitor cells function in mice with or without myocardial infarction, Int. J. Cardiol, vol.221, pp.335-341, 2016. ,
Acute exercise mobilizes hematopoietic stem and progenitor cells and alters the mesenchymal stromal cell secretome, J. Appl. Physiol. Bethesda Md, vol.120, issue.6, pp.624-632, 1985. ,
The safety and efficacy of early-initiation exercise training after acute venous thromboembolism: a randomized clinical trial, J. Thromb. Haemost. JTH, 2015. ,